Soker S - Search Results

1

Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype.

Soker S, Kaefer M, Johnson M, Klagsbrun M, Atala A, Freeman MR. Soker S, et al. Am J Pathol. 2001 Aug;159(2):651-9. doi: 10.1016/S0002-9440(10)61736-1. Am J Pathol. 2001. PMID: 11485923 Free PMC article.

2

Tumor cell-associated neuropilin-1 and vascular endothelial growth factor expression as determinants of tumor growth in neuroblastoma.

Marcus K, Johnson M, Adam RM, O'Reilly MS, Donovan M, Atala A, Freeman MR, Soker S. Marcus K, et al. Among authors: soker s. Neuropathology. 2005 Sep;25(3):178-87. doi: 10.1111/j.1440-1789.2005.00610.x. Neuropathology. 2005. PMID: 16193833

3

Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.

Soker S, Fidder H, Neufeld G, Klagsbrun M. Soker S, et al. J Biol Chem. 1996 Mar 8;271(10):5761-7. doi: 10.1074/jbc.271.10.5761. J Biol Chem. 1996. PMID: 8621443 Free article.

4

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Soker S, et al. Cell. 1998 Mar 20;92(6):735-45. doi: 10.1016/s0092-8674(00)81402-6. Cell. 1998. PMID: 9529250 Free article.

5

Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression.

Miao HQ, Lee P, Lin H, Soker S, Klagsbrun M. Miao HQ, et al. Among authors: soker s. FASEB J. 2000 Dec;14(15):2532-9. doi: 10.1096/fj.00-0250com. FASEB J. 2000. PMID: 11099472

6

Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis.

Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, Peoples GE, Klagsbrun M. Freeman MR, et al. Among authors: soker s. Cancer Res. 1995 Sep 15;55(18):4140-5. Cancer Res. 1995. PMID: 7545086

7

VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding.

Soker S, Miao HQ, Nomi M, Takashima S, Klagsbrun M. Soker S, et al. J Cell Biochem. 2002;85(2):357-68. doi: 10.1002/jcb.10140. J Cell Biochem. 2002. PMID: 11948691

8

In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo.

Schuch G, Machluf M, Bartsch G Jr, Nomi M, Richard H, Atala A, Soker S. Schuch G, et al. Among authors: soker s. Blood. 2002 Dec 15;100(13):4622-8. doi: 10.1182/blood.V100.13.4622. Blood. 2002. PMID: 12453880 Free article.

9

Pancreatic tumor growth is regulated by the balance between positive and negative modulators of angiogenesis.

Schuch G, Kisker O, Atala A, Soker S. Schuch G, et al. Among authors: soker s. Angiogenesis. 2002;5(3):181-90. doi: 10.1023/a:1023893931057. Angiogenesis. 2002. PMID: 12831059

10

Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells.

Schuch G, Heymach JV, Nomi M, Machluf M, Force J, Atala A, Eder JP Jr, Folkman J, Soker S. Schuch G, et al. Among authors: soker s. Cancer Res. 2003 Dec 1;63(23):8345-50. Cancer Res. 2003. PMID: 14678995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters